PLEGRIDY peginterferon beta-1a (rch) 63 microgram/0.5 mL and 94 microgram/0.5 mL solution for injection pre-filled pen TITRATION PACK Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

plegridy peginterferon beta-1a (rch) 63 microgram/0.5 ml and 94 microgram/0.5 ml solution for injection pre-filled pen titration pack

biogen australia pty ltd - peginterferon beta-1a, quantity: 94 microgram - injection, solution - excipient ingredients: arginine hydrochloride; water for injections; sodium acetate trihydrate; polysorbate 20; glacial acetic acid - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).

PLEGRIDY peginterferon beta-1a (rch) 125 microgram/0.5 mL solution for injection pre-filled syringe Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

plegridy peginterferon beta-1a (rch) 125 microgram/0.5 ml solution for injection pre-filled syringe

biogen australia pty ltd - peginterferon beta-1a, quantity: 125 microgram - injection, solution - excipient ingredients: sodium acetate trihydrate; water for injections; glacial acetic acid; arginine hydrochloride; polysorbate 20 - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).

PLEGRIDY peginterferon beta-1a (rch) 63 microgram/0.5 mL and 94 microgram/0.5 mL solution for injection pre-filled syringe TITRATION PACK Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

plegridy peginterferon beta-1a (rch) 63 microgram/0.5 ml and 94 microgram/0.5 ml solution for injection pre-filled syringe titration pack

biogen australia pty ltd - peginterferon beta-1a, quantity: 94 microgram - injection, solution - excipient ingredients: glacial acetic acid; polysorbate 20; arginine hydrochloride; sodium acetate trihydrate; water for injections - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).

PLEGRIDY peginterferon beta-1a (rch) 125 microgram/0.5 mL solution for injection pre-filled pen Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

plegridy peginterferon beta-1a (rch) 125 microgram/0.5 ml solution for injection pre-filled pen

biogen australia pty ltd - peginterferon beta-1a, quantity: 125 microgram - injection, solution - excipient ingredients: sodium acetate trihydrate; glacial acetic acid; water for injections; polysorbate 20; arginine hydrochloride - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).

PLEGRIDY- peginterferon beta-1a injection, solution PLEGRIDY PEN- peginterferon beta-1a injection, solution PLEGRIDY- peginter Združene države Amerike - angleščina - NLM (National Library of Medicine)

plegridy- peginterferon beta-1a injection, solution plegridy pen- peginterferon beta-1a injection, solution plegridy- peginter

biogen inc. - peginterferon beta-1a (unii: i8309403r0) (peginterferon beta-1a - unii:i8309403r0) - peginterferon beta-1a 94 ug in 0.5 ml - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. plegridy is contraindicated in patients with a history of hypersensitivity to natural or recombinant interferon beta or peginterferon, or any other component of plegridy [see warnings and precautions ( 5.3)] . risk summary data from a large population-based cohort study, as well as other published studies over several decades, have not identified a drug-associated risk of major birth defects with the use of interferon beta products during early pregnancy. findings regarding a potential risk for low birth weight or miscarriage with the use of interferon beta products in pregnancy have been inconsistent (see data). in a study in pregnant monkeys, administration of interferon beta during pregnancy resulted in an increased rate of abortion (see data ). in the u.s. general population, the estimated backgro

PLEGRIDY 125 Izrael - angleščina - Ministry of Health

plegridy 125

medison pharma ltd - peginterferon beta 1a - solution for injection - peginterferon beta 1a 125 mcg / 0.5 ml - peginterferon beta-1a - plegridy is indicated in adult patients for the treatment of relapsing remitting multiple sclerosis

PLEGRIDY 63 Izrael - angleščina - Ministry of Health

plegridy 63

medison pharma ltd - peginterferon beta 1a - solution for injection - peginterferon beta 1a 63 mcg / 0.5 ml - peginterferon beta-1a - plegridy is indicated in adult patients for the treatment of relapsing remitting multiple sclerosis

PLEGRIDY 94 Izrael - angleščina - Ministry of Health

plegridy 94

medison pharma ltd - peginterferon beta 1a - solution for injection - peginterferon beta 1a 94 mcg / 0.5 ml - peginterferon beta-1a - plegridy is indicated in adult patients for the treatment of relapsing remitting multiple sclerosis

PLEGRIDY KIT Kanada - angleščina - Health Canada

plegridy kit

biogen canada inc - peginterferon beta-1a; peginterferon beta-1a - kit - 63mcg; 94mcg - peginterferon beta-1a 63mcg; peginterferon beta-1a 94mcg - interferons

Plegridy Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

plegridy

biogen nz biopharma ltd - peginterferon beta-1a 94ug;  ; peginterferon beta-1a 63ug - solution for injection - active: peginterferon beta-1a 94ug   excipient: arginine hydrochloride glacial acetic acid polysorbate 20 sodium acetate trihydrate water for injection active: peginterferon beta-1a 63ug excipient: arginine hydrochloride glacial acetic acid polysorbate 20 sodium acetate trihydrate water for injection - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis